The Potential for Xanthine Oxidase Inhibition in the Prevention and Treatment of Cardiovascular and Cerebrovascular Disease
Cardiovascular Psychiatry and Neurology · 2009
DOI: 10.1155/2009/282059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Psychiatry and Neurology, 2009. Verfasst von Peter Higgins und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular and Medical Sciences, Faculty of Medicine, University of Glasgow, Glasgow G11 6NT, UK. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
There is a now a wealth of epidemiological, animal, and clinical data to suggest the benefits of uric acid reduction and xanthine oxidase inhibition in prevention of vascular disease. This review discusses the available epidemiological, preclinical, and clinical data and considers arguments for and against a role for serum uric acid in common cardiovascular disorders. It concludes that large scale trials with clinical endpoints are justified to address this important question and to define whether use of drugs such as allopurinol should be a routine part of preventative strategies.
Autor:innen und Institutionen
- Division of Cardiovascular and Medical Sciences, Faculty of Medicine, University of Glasgow, Glasgow G11 6NT, UK.
Zitieren
APA
Higgins, P., Dawson, J., & Walters, M. (2009). The Potential for Xanthine Oxidase Inhibition in the Prevention and Treatment of Cardiovascular and Cerebrovascular Disease. Cardiovascular Psychiatry and Neurology. https://doi.org/10.1155/2009/282059
Vancouver
Higgins P, Dawson J, Walters M. The Potential for Xanthine Oxidase Inhibition in the Prevention and Treatment of Cardiovascular and Cerebrovascular Disease. Cardiovascular Psychiatry and Neurology. 2009. doi:10.1155/2009/282059
BibTeX
@article{Higgins2009,
author = {Higgins, Peter and Dawson, Jesse and Walters, Matthew},
title = {The Potential for Xanthine Oxidase Inhibition in the Prevention and Treatment of Cardiovascular and Cerebrovascular Disease},
journal = {Cardiovascular Psychiatry and Neurology},
year = {2009},
doi = {10.1155/2009/282059}
}
EUVIMED